Show simple item record

dc.contributor.authorThatcher, Nicken
dc.contributor.authorWan, H Hen
dc.contributor.authorSwindell, Ricen
dc.contributor.authorWilkinson, Peter Men
dc.contributor.authorCrowther, Dereken
dc.date.accessioned2010-07-21T14:04:31Z
dc.date.available2010-07-21T14:04:31Z
dc.date.issued1982
dc.identifier.citationEffects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients. 1982, 4 (3):167-74 Int J Immunopharmacolen
dc.identifier.issn0192-0561
dc.identifier.pmid7107099
dc.identifier.doi10.1016/0192-0561(82)90045-5
dc.identifier.urihttp://hdl.handle.net/10541/108080
dc.description.abstractThe effects of a single Phenytoin dose, given to patients with malignant melanoma, upon peripheral blood counts, serum immunoglobulins, lymphocyte subpopulations and lymphocytotoxicity (using Chang target cells) were recorded. Sequential blood samples were taken before and 10, 14, 34, 38 and 58 h after the Phenytoin. Early reductions (P less than 0.05) in lymphocyte count, NK, K and PHA induced cytotoxicity, when compared with initial, pre-Phenytoin values were noted. Immunisation with i.v. C. parvum prevented the reductions occurring after a second dose of Phenytoin. Indeed, significant increases above the values of samples taken immediately before the second dose, were observed in T cells, PHA blastogenesis, NK and K cell Cytotoxicity. The second dose did however cause some immunosuppression; the increase in T cells, NK and PHA induced cytotoxicity above initial values expected from previous investigations were not observed. The immunosuppression, particularly of killer cell function, occurring after phenytoin could have implications for the pathogenesis of malignancy and transplacental carcinogenesis, reported as following Phenytoin exposure.
dc.language.isoenen
dc.subject.meshBacterial Vaccines
dc.subject.meshCytotoxicity, Immunologic
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunoglobulin G
dc.subject.meshImmunotherapy
dc.subject.meshKiller Cells, Natural
dc.subject.meshLymphocytes
dc.subject.meshMale
dc.subject.meshMelanoma
dc.subject.meshPhenytoin
dc.subject.meshPhytohemagglutinins
dc.subject.meshPropionibacterium acnes
dc.subject.meshRosette Formation
dc.titleEffects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients.en
dc.typeArticleen
dc.contributor.departmentCancer Research Campaign Department of Medical Oncology, England.en
dc.identifier.journalInternational Journal of Immunopharmacologyen
html.description.abstractThe effects of a single Phenytoin dose, given to patients with malignant melanoma, upon peripheral blood counts, serum immunoglobulins, lymphocyte subpopulations and lymphocytotoxicity (using Chang target cells) were recorded. Sequential blood samples were taken before and 10, 14, 34, 38 and 58 h after the Phenytoin. Early reductions (P less than 0.05) in lymphocyte count, NK, K and PHA induced cytotoxicity, when compared with initial, pre-Phenytoin values were noted. Immunisation with i.v. C. parvum prevented the reductions occurring after a second dose of Phenytoin. Indeed, significant increases above the values of samples taken immediately before the second dose, were observed in T cells, PHA blastogenesis, NK and K cell Cytotoxicity. The second dose did however cause some immunosuppression; the increase in T cells, NK and PHA induced cytotoxicity above initial values expected from previous investigations were not observed. The immunosuppression, particularly of killer cell function, occurring after phenytoin could have implications for the pathogenesis of malignancy and transplacental carcinogenesis, reported as following Phenytoin exposure.


Files in this item

This item appears in the following Collection(s)

Show simple item record